States rebuke drugmakers’ call for “gag order”

States alleging an overarching price-fixing conspiracy in the generic pharmaceutical industry have argued that a court-issued “gag order” sought by defendants would inhibit the responsibility of attorneys general to keep the public informed.

Get unlimited access to all Global Competition Review content